1. Preclinical studies establish SCFAs from Castration-Resistant Prostate Cancer-associated microbiota as key mediators linking dysbiosis to tumor progression;2. CCL20 identified as a potential prognostic biomarker for prostate cancer. This evidence concerns the gene CCL20 and prostate carcinoma.